Alembic Pharmaceuticals

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue1,7841,7171,9171,8921,873
Expenses1,5911,5271,6951,6861,731
EBITDA286.11287.85322.60309.00253.42
Operating Profit216.46213.63247.95184.81141.18
Profit Before Tax191.94190.11223.72161.50118.62
Net Profit156.63153.63183.71131.95201.53
Financial Ratios
Operating Profit Margin16.13%16.80%16.96%14.12%12.44%
Net Profit Margin8.87%9.02%9.67%8.93%11.96%
Earning Per Share (Diluted)7.987.859.406.7610.31
Dividends Per Share0.000.000.000.000.00